Commercial Business Measurement Period Handbook For Patient-Centered Primary Care
|
|
- Brent Williamson
- 6 years ago
- Views:
Transcription
1 Commercial Business Measurement Period Handbook For Patient-Centered Primary Care Measurement Period beginning: 07/01/16 CB Version V1
2 Introduction: Welcome to your Commercial Business Measurement Period Handbook. As explained in the Program Description, the Incentive Program gives you the opportunity to share in savings achieved by your Medical Panel during a given Measurement Period. If you meet both quality and cost performance targets, your provider organization could share in the cost savings. To determine whether or how much of a shared savings payment you are eligible for, we measure your performance against quality, utilization and cost targets. In this handbook, you ll have the chance to learn more about those targets and how you can learn more about your performance. Below you will see definitions of some of the most important terms used in this handbook and the details of your Incentive Program: Medical Cost Target Report. Prior to the start of your Measurement Period, or as soon thereafter as practicable, you will be able to access your provider organization s Medical Cost Target (MCT) report via our secure website. The Medical Cost Target report shows medical costs incurred by your Attributed Patients over the course of the Baseline Period. This information is used as the starting point for the projected medical trends used to establish the Medical Cost Targets (MCTs) for the Incentive Program. You are eligible to earn shared savings when the Medical Cost Performance (MCP) during the Measurement Period comes in below the MCT (with consideration to the Risk Corridor), and your measured performance on quality metrics and outcomes meets or exceeds the Program s Quality Gate. Measurement Period Start Date. The first day of the twelve (12) month period during which we measure Medical Cost Performance (MCP) and quality and utilization performance for purposes of calculating shared savings between UniCare and the Medical Panel. Quality Gate. The minimum clinical quality scores that your provider organization must deliver in order to earn any shared savings under the Incentive Program. Your quality gate will be set at 10 th percentile. Further information about the Quality Gate is reviewed in the shared savings section, on page 10. Upside Shared Savings Potential. The maximum percentage of savings under the Incentive Program that you may be entitled to share, as long as your provider organization meets the Quality Gate and other Non-Cost Program Targets. Minimum Risk Corridor (MRC) the percentage of MCT that UniCare retains before sharing any savings with the Medical Panel. This percentage is determined by UniCare and is designed to limit savings payouts that are driven by random variation. Upside Cap The maximum Incentive Program shared savings that you can earn through the Incentive Program. As is the case with the Gross Savings, the Upside Cap is adjusted by the Paid/Allowed Ratio as defined in the Program Description. Performance Scorecard Report. In addition to the MCT report, you will also be able to access your provider organization s Performance Scorecard via our secure website ( The Performance Scorecard shows your performance on the selected clinical, quality and utilization measures listed in this handbook. The Performance Scorecard is a tool to help you assess your quality and utilization performance on a quarterly basis. The information included in this handbook is designed to help you understand your Medical Cost Target report, your Performance Scorecard and the scoring methodology.. 2 CB Version V1
3 Table of Contents Introduction:... 2 Section 1: Medical Cost Target... 4 Where to Find Your MCT Report and Supporting Materials... 4 Section 2: Performance Scorecard & Your Measures... 5 Overview... 5 Scorecard Report Example... 5 Quality Measures for Your Measurement Period... 6 Section 3: Calculating Your Shared Savings... 9 Overview... 9 Quality Gate Did you pass the Quality Gate?... 9 Weighting Composites Calculating Composite Scores Summary of your scoring INDEX Scorecard Measure Specifications CB Version V1
4 Section 1: Medical Cost Target Overview As part of our Enhanced Personal Health Care Program, we track overall medical costs incurred by our members, and under the incentive portion of the Program, we reward participating providers who are able to provide appropriate care in a cost-effective manner while maintaining or improving performance against nationally recognized quality measures. The Medical Cost Target Report shows medical costs incurred by a given Medical Panel s Attributed Members over the course of the Baseline Period. This information is used to establish the Medical Cost Targets (MCTs) for the Incentive Program. The Medical Cost Target Report lists supporting Member Months, average risk scores and claims expenditures incurred by Attributed Members over the course of the Baseline Period. You are eligible to earn shared savings if your performance during the Measurement Period creates Net Savings (i.e., costs in the Measurement Period come in lower than projected) and if you meet or exceed the Program s quality benchmarks. The better the quality score, the higher the potential shared savings payment. The Medical Cost Target Report is meant to give you a sense of the baseline cost trend from which you are starting. This level-set helps you hit the ground running at the beginning of the Measurement Period for the Incentive Program. This report is produced at the start of each annual Measurement Period. You will receive periodic reports that show your Medical Cost Performance (MCP) over the course of the. Where to Find Your MCT Report and Supporting Materials Your MCT report will be available within 45 days following the start of your Measurement Period or as soon thereafter as practicable. To view your MCT report or to view a useful Quick Reference Guide for MCT, select the Provider Online Reporting link on Availity.com. 4 CB Version V1
5 Section 2: Performance Scorecard & Your Measures Overview The performance scorecard is comprised of Clinical Quality and Utilization Measures. In addition to serving as a basis for Incentive Program savings calculations, these measures are used to establish a minimum level of performance expected of you under the Program, and to encourage improvement through sharing of information. The performance scorecard allows you to monitor your progress in these measures throughout the. It will identify: Historic measure rate during the Baseline Period Rolling measure rate Rolling measure numerator and denominator Benchmarks for your Measurement Period Scorecard Report Example The Performance Scorecard report includes information for providers on: Earned Contribution: The proportion of the Shared Savings Potential earned for each Scorecard category and for the overall Program. Maximum Possible Shared Savings: The maximum percentage (out of 100%) of Shared Savings to which the provider is entitled under the Incentive Program. 5 CB Version V1
6 Quality Measures for Your Measurement Period Clinical Quality Measures The clinical quality measures for the Program are grouped into two categories: (1) Acute and Chronic Care Management and (2) Preventive Care. These categories are then further broken out into six subcomposites. These measures cover care for both the adult and pediatric populations. Nationally standardized specifications are used to construct the quality measures in conjunction with Plan data. Acute and Chronic Care Management Measures o Medication Adherence - Proportion of Days Covered (PDC): Oral Diabetes - Proportion of Days Covered (PDC): Hypertension (ACE or ARB) - Proportion of Days Covered (PDC): Cholesterol (Statins) o o Diabetes Care - Diabetes: Urine Protein Screening - Diabetes: HbA1c Testing - Diabetes: Eye Exam Annual Monitoring for Persistent Medications - Annual Monitoring for Patients on Persistent Medications: Digoxin - Annual Monitoring for Patients on Persistent Medications: ACE/ARB - Annual Monitoring for Patients on Persistent Medications: Diuretics o Preventive Measures o o Other Acute and Chronic Care Measurement - Appropriate Testing for Children with Pharyngitis - Appropriate Treatment for Children with Upper Respiratory Infection - Osteoporosis Management in Women Who Had a Fracture - Persistence of Beta-Blocker Treatment After a Heart Attack - Arthritis: Disease Modifying Anti-rheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis - Use of appropriate medication for people with Asthma - New Episode of Depression: Effective Acute Phase Treatment - New Episode of Depression: Effective Continuation Phase Treatment Pediatric Prevention - Childhood Immunization Status: MMR - Childhood Immunization Status: VZV - Well-Child Visits Ages 0-15 Months - Well-Child Visits Ages 3-6 Years Old - Well-Child Visits Ages Years Old Adult Prevention - Breast Cancer Screening - Cervical Cancer Screening 6 CB Version V1
7 Utilization Measures Three different utilization measures are included in the Program scorecard. The measures focus on appropriate emergency room (ER) utilization, management of ambulatory-sensitive care conditions as measured by hospital admissions, and generic dispensing rates for a select set of drug classifications. As with the clinical metrics, administrative data are used to construct the utilization measures. Potentially Avoidable ER Visits This measure was developed using research that determines ER visits that were potentially avoidable by identifying visits that could have been treatable in an ambulatory care setting. Visits for treatment of conditions, such as the following, are considered potentially avoidable: Conjunctivitis Otitis media Sinusitis Bronchitis Sinusitis Gastritis Constipation Urinary tract infection Menstrual disorders Cellulitis Dermatitis Sun burn Osteoarthrosis Joint pain Backache Cramps Insomnia Malaise and fatigue Throat pain Cough Nausea or vomiting alone Diarrhea Sprains Abrasions Contusions First degree burns Strep throat Vaccinations Routine child Prenatal Gynecological and adult exams Change of wound dressings Radiology and laboratory exams Health screenings. Ambulatory Sensitive Care Hospital Admissions The Agency for Healthcare Research and Quality (AHRQ) has developed a Prevention Quality Indicators (PQI) composite measure of 11 potentially avoidable hospitalizations for ambulatory care sensitive conditions that are the basis of this measure. They are: 1. Diabetes short-term complications 2. Diabetes long-term complications 3. Chronic obstructive pulmonary disease or asthma in older adults 4. Hypertension 5. Heart Failure 6. Dehydration 7. Bacterial pneumonia 8. Urinary tract infection 9. Angina without procedure 10. Uncontrolled diabetes 11. Asthma in younger adults 7 CB Version V1
8 Generic Dispensing Rate We assess the generic dispensing rate for five classes of medication: 1. Statins 2. ADHD Medications 3. ARBs and ARB Combinations 4. Beta Blockers and Beta Blocker Combinations 5. Serotonin Agonists and Serotonin Agonist Combinations (Migraine Medications) Quality Improvement Measures In addition to assessing performance against thresholds, a subset of the clinical measures (listed below) will be scored for improvement. The selection of these measures is a subset of the current set of performance measures. These improvement measures will be assessed at your provider organization level and will be weighted equally for each measure that has a denominator greater than or equal to 30. If the denominator for each of the improvement measures is less than 30, then we will not use a score for that category. 1. Breast Cancer Screening 2. Medication Adherences: Statins 3. Diabetes: HbA1c Testing 4. Well Child Visits ages 3-6 Years Old 5. Appropriate Testing for Children with Pharyngitis Composite Overview Scorecard points are divided into five categories, or composites. Several of the composites are based upon subcomposites. Then, within some of the sub-composites there are specific care measures. Performance on the clinical measures listed above will be calculated at the sub-composite level. The sub-composites are scored as the sum of the numerators for the measures within the sub-composite divided by the sum of the denominators. Scoring of the clinical measure sub-composites occurs at the provider organization level. If all of the clinical sub-composites have a denominator less than 30, or if the Annual Monitoring for Persistent Medications is the only clinical sub-composite with a denominator of at least 30, then scoring will occur at the Medical Panel-level. The Utilization Measures will always be scored at your Medical Panel-level to achieve sufficient denominator sizes for meaningful measurement. The four major composites are: 1. Acute and Chronic Care Management 2. Preventive Care 3. Utilization 4. Clinical Quality Improvement Composite Details 1. The Acute and Chronic Care Management Composite has four sub-composites. Each of the sub-composites has multiple care measures that contribute to the Acute and Chronic Care Management calculation: Medication Adherence Diabetes Care Annual Monitoring for Persistent Medications Other Acute and Chronic Care Management 8 CB Version V1
9 2. The Preventive Care Composite has two sub-composites, with five individual care measures: Adult Preventive Pediatric Preventive 3. The Utilization Composite is made up of three sub-composites: Potentially avoidable ER visits Admissions for ambulatory sensitive care Generic drug dispensing rate for five classifications 4. The Clinical Quality Improvement Composite has four measures, and was outlined previously. Section 3: Calculating Your Shared Savings Overview The opportunity to share in savings that are realized for your Attributed Members is a key characteristic of the Program. After savings are determined, the proportion of shared savings that you can earn depends on your organization s performance on a scorecard. Your Scorecard serves two functions: (1) it will let you know if you met the Quality Gate, and (2) it will show you the overall percentage of the shared savings you earn. Below, we review the four major steps to determine your shared savings: 1. Savings Pool Funded 2. Quality Gate Passed 3. Earned Contribution Calculated for each Composite 4. Overall Shared Savings Potential Calculated Savings Pool Funded Was the savings pool funded? In order to participate in shared savings, the Savings Pool must be funded. For that to happen, your Medical Panel s Attributed Member population must demonstrate savings over the course of your Measurement Period. As described more fully in the Program Description, UniCare will calculate the Savings Pool by comparing the Medical Cost Performance (MCP) for your Attributed Member population for a specified 12 month Measurement Period to the established Medical Cost Target (MCT). In the event that the MCP is less than the MCT, the Savings Pool is funded. After the pool is funded, the Minimum Risk Corridor (MRC) is calculated by multiplying the MCT by the MRC, and then multiplying the result with the Paid/Allowed Ratio (as outlined further in the Program Description). Ultimately, the Savings Pool is multiplied by your Shared Savings Percentage earned to calculate your shared savings payout. Quality Gate Did you pass the Quality Gate? Your provider organization must meet a minimum threshold of performance on clinical quality measures in order for you to share a portion of the savings pool. That threshold, referred to as the Quality Gate, is based on an overall clinical quality score, which is computed by aggregating your scores across the scorecard s clinical sub-composites. We calculate that score for the Measurement Period and compare it to the distribution of performance across the market for the same time period. The market distribution of performance includes provider organizations (including primary care 9 CB Version V1
10 and specialist providers, whether participating in the Program or not) that have at least one of the 6 quality subcomposites with a denominator of 30 or more. Your provider organization s clinical quality score must meet or exceed the market 10th percentile to pass the Quality Gate. For provider organizations with denominators of at least 30 in all 6 clinical sub-composites, the sub-composite rates are proportionally weighted by the assigned Shared Savings Potential to arrive at the overall clinical quality score. When provider organizations have one to five sub-composites with denominators of 30 or more, the weights are redistributed accordingly and then a final overall quality composite score is calculated. If your overall quality composite score is greater than the Quality Gate, you are eligible to earn shared savings. Examples follow in the tables below: 10 CB Version V1
11 Table 1: Clinical Sub-Composites and Weights for Calculating the Overall Quality Composite: In this example the group had sufficient denominators to be scored in all categories. The Quality Gate, using the 10 th percentile, equates to a 22% performance rate across all sub-composites. When the sub-composite scores are aggregated proportional to the weights, the group has an overall score of 42%. Since the Quality Gate was set at 22%, this group would pass the Quality Gate. Example One Clinical Sub-Composites Performance Rate Weight Medication Adherence % 25.0% 11% Diabetes Care % 12.5% 3% Annual Monitoring for Persist Meds % 5.0% 4% Other Acute and Chronic Care Management % 20.0% 14% Pediatric Preventive % 12.5% 3% Adult Preventive % 25.0% 7% 100% QUALITY GATE 42% Overall Contribution Percentage Table 2: Clinical Sub-Composites and Weights for Calculating the Overall Quality Composite: In this example the group did not have sufficient denominators to be scored in all categories, so the weights were proportionally redistributed accordingly, producing an overall quality composite score of 45%. Since the Quality Gate was set at 22%, this group would pass the Quality Gate. Example Two Clinical Sub-Composites Performance Rate Weight Overall Contribution Percentage Medication Adherence % 28.6% 13% Diabetes Care % 14.3% 4% Annual Monitoring for Persist Meds % 5.7% 5% Other Acute and Chronic Care Management % 22.9% 16% Pediatric Preventive NA NA NA Adult Preventive % 28.6% 8% 100% QUALITY GATE 45% 11 CB Version V1
12 Weighting Composites The composite, sub-composites, and care measures do not contribute equally to the Scorecard s results they are weighted more heavily toward Clinical Measures: The Acute and Chronic Care composite is weighted more heavily than preventive care. Utilization measures account for 40% of the scorecard points. Table 3: Composite Weights - Example Category Allocation of Shared Savings Potential Clinical: Acute and Chronic Care Management Medication Adherence Diabetes Care Annual Monitoring for Persist Meds Other Acute and Chronic Care Management Pediatric Adult Clinical: Improvement Utilization TOTAL Clinical: Preventive % Table 4: Shared Savings Potential per Composite in Absolute Terms - Example Category Proportion of Shared Savings Clinical: Acute and Chronic Care Management Medication Adherence 4.20% Diabetes Care 2.10% Annual Monitoring for Persist Meds 0.84% Other Acute and Chronic Care Management 3.36% Clinical: Preventive Pediatric 2.10% Adult 4.20% Clinical: Improvement 4.20% Utilization 14.00% TOTAL 35% 12 CB Version V1
13 Calculating Composite Scores As mentioned above, there are five composites that are calculated for the scorecard. Each area is explained in detail below. Composites 1 & 2: Acute and Chronic Care Management and Preventive Care Measures We use four steps to determine the proportion of shared savings earned for the acute and chronic care management and preventive care. The table below is a visual representation of the process. Table 5: The Four Steps That Are Used to Calculate for Preventive Care Measures - Example Organizations Current Performance Market Thresholds Shared Savings Adult Preventive Sub-composite Eligible Population Compliant with Measure Rate Level 1-20th percentile Earned Shared Savings = 30% Level 2-40th Percentile Earned Shared Savings 50% Level 3-60th Percentile Earned Shared Savings 70% Level 4-80th Percentile Earned Shared Savings 100% Measurement Level Earned Contribution Upside Shared Savings Potential Shared Savings Percentage % 52% 60% 65% 72% Group 50% 4.20% 2.1% Step 1 Step 2 Step 3 Step 4 Step 1. Calculate sub-composite rate Sub-composite rates are calculated by summing- the numerators (the number compliant with measure) across each of the measures within the sub-composite, and then dividing by the sum of the denominators (eligible population). Step 2. Compare performance to market thresholds Market thresholds are established for each of the sub-composites at the <20th, 20th, 40th, 60th and 80th percentiles for the prior to the Program Measurement Period. Performance thresholds will be provided soon after the start of the Measurement Period The thresholds are set jointly for all lines of business included in the Program using performance of all providers within the market. Provider organizations with a sub-composite denominator less than 30 are excluded from the calculation of the relevant sub-composite thresholds. 13 CB Version V1
14 Step 3. Assign percentage of the category earned The four levels of market thresholds are used to categorize four (4) tiers of performance. After passing the lowest market threshold, each performance tier is associated with a greater proportion of earned shared savings: (0 - < 20th percentile) = 0% of shared savings earned Level 1 (20th-<40th percentile) = 30% of shared savings earned Level 2 (40th-<60th percentile) = 50% of shared savings earned Level 3 (60th-<80th percentile) = 70% of shared savings earned Level 4 (80th -<100th percentile) = 100% of shared savings earned Step 4. Calculate shared savings earned After the percentage of the category earned is determined, that value is multiplied by the group s Upside Shared Savings Potential for the Sub-composite. This yields the earned shared savings for the subcomposite. 14 CB Version V1
15 Composite 3: Utilization Measures Calculated We use five steps to determine the proportion of shared savings earned for each utilization sub-composite. Table 6 uses sample data to show hypothetical calculations. Table 6: The Five Steps That Are Used to Calculate Utilization Measures - Example Measures Member Months Current Performance Market Benchmark Shared Savings Visits Risk Adj. Factor Risk Adj. Rate Level 1 Level 2 Level 3 Level 4 Upside Shared Savings Potential Earned Contribution Shared Savings % Commercial Adult 98, % 30.00% 0.89% Commercial < 18 18, % 00.00% 0.00% Weighted Subcomposite Total: 3.50% 25.33% 0.89% Step 1 Step 2 Step 3 Step 4 Step 5 Step 1 Calculate utilization rates for the Medical Panel for distinct line of business and age categories. Ambulatory Sensitive Admits and Potentially Avoidable ER measures: o To control for variation in patient mix and associated variable utilization between Medical Panels, utilization rates are calculated separately for: Commercial members at least 18 s of age Commercial members less than 18 s of age o The numerator is the count of qualifying events during the Measurement Period. o The denominator is the sum of Member Months for members attributed to the Medical Panel during the Measurement Period. o The unadjusted rate is computed as (numerator/denominator)*12,000. o This rate is risk-adjusted by dividing the actual raw rate for the provider panel by the relative risk score. o The Medical Panel risk score is calculated as the sum of weighted retrospective Diagnostic Cost Grouping risk scores for members attributed to the Medical Panel, divided by number of Attributed Members with a risk score. That rate is then divided by the average Risk Score of all members within the line of business/age group. Generic Dispensing Rates o To control for variation in patient mix and associated variable utilization between Medical Panels, utilization rates are calculated separately for: Commercial members at least 18 s of age Commercial members less than 18 s of age The Generic Dispensing Rate is calculated separately for each of the five therapeutic classes. = count of all prescriptions for the Medical Panel s attributed patient population within each of the five generic classes. 15 CB Version V1
16 o = count of generic prescriptions during Measurement Period within each of the five generic classes. o The rate is computed as (numerator/denominator) percentage for each line of business/age group within each of the five generic classes separately. Step 2 Compare performance to market thresholds. o Market Thresholds are established for each of the utilization measures for three distinct line of business/age groups (commercial adult, commercial <18). o Four levels of thresholds are calculated based on the overall market: <20th, 20th, 40th, 60th and 80th percentiles for the prior to the Program Measurement Period. o We will provide performance thresholds soon after the start of the Measurement Period. Step 3 Determine Shared Savings Potential for each line of business/age group. o Upside shared savings -Potential for the utilization measures: o Potentially avoidable emergency room visits = 3.5% o Generic dispensing rate (GDR) = 7% o Ambulatory sensitive care admissions = 3.5% o Since these measures are assessed by line of business/age groups, the shared savings opportunity for each of these groups must be determined. o Upside shared savings opportunity for each GDR drug class is determined by distributing the overall Upside Shared Savings Potential for GDR (7%) based on the proportion of prescriptions within that drug class compared to the overall (total) GDR prescription count. o Within each drug class, the shared savings opportunity is determined for each line of business age/group based on the proportion of prescriptions within that line of business/age group. Step 4 Assign the earned contribution percentage. The four levels of market thresholds are used to categorize four tiers of performance. After passing the lowest market threshold, each performance tier is associated with a greater proportion of earned shared savings: o (0 - < 20th percentile) = 0% of shared savings earned o Level 1 (20th-<40th percentile) = 30% of shared savings earned o Level 2 (40th-<60th percentile) = 50% of shared savings earned o Level 3 (60th-<80th percentile) = 70% of shared savings earned o Level 4 (80th -<100th percentile) = 100% of shared savings earned Step 5 Calculate earned shared savings for each utilization measure and the overall category. The earned shared savings for each measure/group combination is calculated by multiplying the percentage of the category earned for each line of business/age group for each of the utilization measures by the Medical Panel s Maximum Upside Shared Savings Potential. These scores are summed to determine the overall percentage of shared savings for each of the Utilization Metrics, and then summed for an overall utilization shared savings earned. 16 CB Version V1
17 Overall Scoring Summary for Utilization Components The chart below demonstrates how steps 3, 4 and 5, described above, are used to calculate the overall score for the utilization subcomponents. 3. Determine Upside Shared Savings Potential for each line of business/age group. 4. Assign the earned contribution percentage. 5. Calculate earned shared savings for each utilization measure and the overall category. Table 7: Overall scoring for Utilization Measures - Example Step 4 Step 3 Step 5 17 CB Version V1
18 Composite 4: Clinical Quality Improvement Components Calculated There are five clinical improvement measures selected from the clinical quality measures as follows: 1. Breast cancer screening 2. Medication adherence: statins 3. Diabetes: HbA1c Testing 4. Well child visits for ages 3-6 Years old 5. Appropriate testing for children with pharyngitis Scoring of this scorecard component is performed only at the individual provider organization level. Performance is measured as follows: Rates are calculated for each of the five clinical improvement measures where the denominator size is 30 or more for both Measurement Periods. Weights for measures with a denominator less than 30 are reallocated to the remaining Improvement Measures. A target rate is set for each of the improvement measures. This target represents an improvement of 20% in closing the quality gap. (1-Group Baseline Rate)*.20)+group baseline rate If the target is achieved, you will receive full credit for that measure. Additionally, if the current rate is 90% or higher, full credit is received. Scoring for Improvement Measures will always take place at the group level. Each of the five improvement measures will be weighted equally at 20%. If your denominator less than 30 for any measure, that measure will not be scored but the weighting will be redistributed to the remaining measures with sufficient denominator size. If none of the five measures have a denominator of 30 or more, no points will be awarded or reallocated for the improvement component. 18 CB Version V1
19 Summary of your scoring The tables below pull together all of the scoring that is described in this Measurement Period Handbook. The performance of your Medical Panel is used to calculate a score (0-100%) for each scorecard component. Your shared savings for each scorecard component is calculated by multiplying the Upside Shared Savings Potential (shown above in table 4) by the category score. The sum of your earned shared savings for each scoring components yields your overall earned shared savings examples of this calculation are shown in Tables 8 below. The table below, which you will receive with your scorecard posted to Availity, will show: Whether you passed the Quality Gate, and The overall percentage of shared savings that you have earned for the Measurement Period. Table 8: In this example, the provider organization would earn % of a Shared Savings Pool. Summary one - Without NCQA PCMH Recognition - Example Category Passed Quality Gate (10th percentile) > (1) Clinical: Acute and Chronic Care Mgmt % Savings Potential Category % Earned Medication Adherence 4.20% 70% 2.94% Diabetes Care 2.10% 50% 1.05% Annual Monitoring for Persistent Medications 0.84% 0% 0.00% Other Acute and Chronic Care 3.36% 100% 3.36% (2) Clinical: Preventive 6.30% Pediatric Preventive 2.10% 15% 0.32% Adult Preventive 4.20% 70% 2.94% (3) Clinical: Improvement 4.20% 75% 3.15% (4) Utilization 14.00% 50% 7.00% OVERALL SAVINGS POTENTIAL 35% Savings Earned EARNED SHARED SAVINGS 20.76% YES 19 CB Version V1
20 INDEX Scorecard Measure Specifications Acute and Chronic Care Management Measures Sub-composite: Medication Adherence Measure Description / Technical Specifications Measure Citation Proportion of Days Covered (PDC): Oral Diabetes Attributed Members with at least two prescriptions for diabetic oral agents in the who have at least 80% days covered (PDC) since the first prescription of an oral diabetic agent during the. Attributed Members in the denominator with at least 80% days covered for an oral diabetic Rx since the first prescription for the drug during the last 365 days Attributed Members who have at least two prescriptions for an oral diabetic drug during the last 365 days >=80% days covered (PDC) for Diabetic Oral Agents (removing overlapping days for Rx) from index event to end of >=2 Rx claims for diabetic oral agents from end of -365 to end of, saving earliest instance as index event (IE); Rx eligibility from index event to end of using HEDIS gap method, <=1 gap <=45 days max; >=18yo No Rx claims for 'Insulin' from index event to end of CMS Part D Specifications 2014 Proportion of Days Covered (PDC): Hypertension (ACE or ARB) Attributed Members with at least two prescriptions for an ACE/ARB in the who have at least 80% days covered (PDC) since the first prescription of an ACE/ARB during the. Attributed Members in the denominator with at least 80% days covered for an ACE/ARB since the first prescription for the drug during the last 365 days Attributed Members who have at least two prescriptions for an ACE/ARB during the last 365 days Attributed Members in the denominator with at least 80% days covered for a Statin since the first prescription for the drug during the last 365 days Attributed Members who have at least two prescriptions for a Statin during the last 365 days >=80 days covered (PDC) for ACE/ ARB (removing overlapping days) from index event to end of >=2 Rx claims for ACE/ ARB from end of -365 to end of measurement, saving earliest instance as index event (IE); Rx eligibility from index event to end of, using HEDIS gap method, <=1 gap <=45 days max; >=18yo CMS Part D Specifications 2014 Proportion of Days Covered (PDC): Cholesterol (Statins) Attributed Members with at least two prescriptions for a Statin in the who have at least 80% days covered (PDC) since the first prescription of a Statin during the. >=80% days covered (PDC) for Statins (removing overlapping days) from index event to end of >=2 Rx claims for Statins from end of -365 to end of measurement, saving earliest instance as index event (IE); Rx eligibility from index event to end of using HEDIS gap method, <=1 gap <=45 days max; >=18yo CMS Part D Specifications CB Version V1
21 Sub-composite: Diabetes Care Measure Description / Technical Specifications Measure Citation Diabetes: Urine Protein Screening Attributed Members between 18 and 75 s old who have diabetes and at least one nephropathy screening; or who had evidence of medical attention for existing nephropathy (diagnosis or treatment of nephropathy), who are taking ACE-I/ARBs, or who have had at least one visit with a nephrologist. The number of Attributed Members from the denominator who during the had at least one test for nephropathy screening; or who had evidence of medical attention for existing nephropathy (diagnosis or treatment of nephropathy), who are taking ACE-I/ARBs, or who have had at least one visit with a nephrologist Attributed Members with diabetes diagnosed during the or the prior to the Any one of the following during the measurement : 1 lab procedure for a urine microalbumin or macroalbumin test 1 procedure or diagnosis for treatment for nephropathy (including dialysis) 1 outpatient visit with a nephrologists specialist 1 Rx claim for ACE Inhibitors/ARBs Age of s as of the end of the AND meet NCQA/HEDIS criteria for diabetes diagnosis, identified during the or the prior AND have service eligibility during the AND exclude Attributed Members who meet NCQA/HEDIS criteria for diagnosis of polycystic ovaries any time during the Attributed Member s history through the end of the AND exclude Attributed Members who meet NCQA/HEDIS criteria for diagnosis of gestational diabetes or steroid-induced diabetes in any setting, during the or the prior to the. National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, Diabetes: HbA1c Testing Attributed Members between 18 and 75 s old who have diabetes and who had at least 1 HbA1c test during the measurement. Attributed Members in the denominator who had at least one serum HbA1c test during the measurement Attributed Members with diabetes diagnosed during the or the prior to the 1 claim for a HbA1c test during the measurement Age of s as of the end of the ; AND meet NCQA/HEDIS criteria for the diagnosis of Diabetes, identified during the measurement or the prior; AND have service eligibility during the ; AND exclude Attributed Members who meet NCQA/HEDIS criteria for diagnosis of polycystic ovaries any time during the Attributed Member s history through December 31 of the measurement AND exclude Attributed Members who meet NCQA/HEDIS criteria for diagnosis of gestational diabetes or steroid-induced diabetes in any setting, during the or the prior to the. National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, CB Version V1
22 Measure Description / Technical Specifications Measure Citation Diabetes: Eye Exam Attributed Members between 18 and 75 s old who have diabetes and who had a retinal eye exam from an eye care professional in the last 2 s. Attributed Members in the denominator who received a retinal eye from an eye care professional in the last 730 days. Attributed Members identified as having diabetes during the measurement or the prior to the. 1 claim for a visit with an eye care professional in the last 730 days. Note: HEDIS specifications only count retinal eye exams from the previous if the results were negative, but due to data limitations this measure was loosened to accept all eye exams from the previous regardless of result. Age of s as of the end of the AND meet NCQA/HEDIS criteria for diabetes diagnosis, identified during the or the prior AND have service eligibility during the AND exclude Attributed Members who meet NCQA/HEDIS criteria for diagnosis of polycystic ovaries any time during the Attributed Member s history through the end of the Measurement Period. AND exclude Attributed Members who meet NCQA/HEDIS criteria for diagnosis of gestational diabetes or steroid-induced diabetes in any setting, during the or the prior to the. National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, CB Version V1
23 Sub-composite: Annual Monitoring for Persistent Medications Measure Description / Technical Specifications Measure Citation Annual Monitoring for Patients on Persistent Medications: Digoxin Attributed Members age 18 or older who had at least a 50% medication possession ratio (MPR) for digoxin during the who had at least 1 serum potassium and either a serum creatinine or a blood urea nitrogen (BUN) therapeutic monitoring test during the measurement. Attributed Members in the denominator who had at least one serum potassium and either a serum creatinine or a BUN test during the measurement Attributed Members who had at least a 50% MPR for digoxin during the 1 claims for a lab panel test AND 1 claims for a serum digoxin test during the OR 1 claims for a serum potassium test AND 1 claims for serum creatinine test AND 1 claims for a serum digoxin test during the Age 18 s as of the end of the measurement AND have service and Rx eligibility during the (HEDIS criteria) AND continuous Rx use of digoxin for at least 180 days during the AND no inpatient hospitalizations during the National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, Annual Monitoring for Patients on Persistent Medications: ACE/ARB Attributed Members age 18 or older who received at least a 50% medication possession ratio (MPR) for ACE inhibitors or ARBs during the measurement who had at least one serum potassium and either a serum creatinine or a blood urea nitrogen (BUN) test during the. Attributed Members in the denominator who had at least one serum potassium and either a serum creatinine or a BUN test during the measurement Attributed Members who had at least a 50% MPR for ACE inhibitors or ARBs during the measurement 1 claims for a lab panel test during the OR BOTH 1 claims for a serum potassium test AND 1 claims for serum creatinine test during the Age 18 s as of the end of the measurement AND have service and Rx eligibility during the (HEDIS criteria) AND continuous Rx use of ACE/ARBs for at least 180 ambulatory treatment days during the last AND no inpatient hospitalizations during the National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, CB Version V1
24 Measure Description / Technical Specifications Measure Citation Annual Monitoring for Patients on Persistent Medications: Diuretics Attributed Members age 18 or older who had at least a 50% medication possession ratio (MPR) for diuretics during the who had at least 1 serum potassium and either a serum creatinine or a blood urea nitrogen (BUN) therapeutic monitoring test during the. Attributed Members in the denominator who had at least one serum potassium and either a serum creatinine or a BUN therapeutic monitoring test during the measurement Attributed Members who had at least a 50% MPR for diuretics during the 1 claims for a lab panel test during the OR BOTH 1 claims for a serum potassium test AND 1 claims for serum creatinine test during the Age 18 s as of the end of the measurement AND have service and Rx eligibility during the (HEDIS criteria) AND continuous Rx use of diuretics for at least 180 ambulatory treatment days during the last AND no inpatient hospitalizations during the National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, CB Version V1
25 Sub-composite: Other Acute and Chronic Care Measurement Measure Description / Technical Specifications Measure Citation Appropriate Testing for Children with Pharyngitis children 2 18 s of age who were diagnosed with pharyngitis prior to or during the measurement, dispensed an antibiotic, and had a test for group A streptococcus for the episode. Attributed Members in the denominator who had a test for group A streptococcus (strep) for the episode of pharyngitis Children age 2 to 18 who were diagnosed with pharyngitis and dispensed an antibiotic within six months prior to the or during the first 6 months of the 1 lab claim for a Group A strep test from 3 days before to 3 days after the date of onset of pharyngitis At least 2 s old 18 months prior to the end of the AND less than 18 s old 6 months prior to the end of the AND at least 1 medical claim for Pharyngitis as a solitary primary diagnosis between 30 and 365 days prior to the end of the, excluding claims from Acute Inpatient or an Outpatient facility that is followed by an ER visit within 2 days. Save earliest claim as Pharyngitis onset date AND have no Rx claims for an URI Antibiotic during the period of 30 days prior to Pharyngitis onset date but not including the onset date AND have service and Rx eligibility from 30 days before to 3 days after date of onset of pharyngitis AND have active Rx for an URI Antibiotic from 0 to 3 days after Pharyngitis onset date National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, Appropriate Treatment for Children with Upper Respiratory Infection children age 3 months to 18 s who were diagnosed with an upper respiratory infection (URI) who did not receive an antibiotic prescription within three days after diagnosis Attributed Members in the denominator who did not receive an antibiotic prescription within three days after the diagnosis Children age 3 months old as of 18 months prior to the end of the measurement to 18 s old 6 months prior to the end of the who were diagnosed with URI between 545 and 180 days prior to the end of the No claims for a URI Antibiotic between 0 and 3 days after the URI episode date At least 3 months old 18 months prior to the end of the AND less than 18 s old 6 months prior to the end of the AND meet criteria for URI according to HEDIS; must be a primary solitary diagnosis for URI, excluding claims from an Inpatient or an Outpatient facility that is followed by an ER visit within 2 days AND the URI episode date occurs between 545 and 184 days prior to the end of the measurement AND have member and Rx eligibility 30 days prior to 3 days after the URI episode date AND no Rx claims for an Antibiotic between 1 and 30 days prior to date of onset of URI AND no active days supply for an Antibiotic on the date of onset of URI AND no claims for a competing diagnosis based on HEDIS criteria on the URI episode date or 3 days following the URI episode date National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, CB Version V1
26 Measure Description / Technical Specifications Measure Citation Osteoporosis Management in Women Who Had a Fracture women age 67 or older who suffered a bone fracture and had either a bone mineral density (BMD) test or a prescription for a drug to treat or prevent osteoporosis during the six months after the date of fracture. Attributed Members in the denominator who had either a bone mineral density test or a prescription for a drug to treat or prevent osteoporosis in the 6 months after the date of fracture Women who are 67 s or older who suffered a bone fracture during the 6 months prior to the measurement or during the first 6 months of the measurement 1 claim for osteoporosis drugs from 0 to 180 days following the index episode of bone fracture OR at least 1 claim for a BMD test from 0 to 180 days following the index episode of bone fracture 67 to 85 s old as of the end of the AND Female AND had a claim for bone fracture during the 6 months prior to the through the first 6 months of the, with the earliest date of bone fracture diagnosis being the index episode AND no claims for bone fracture 60 days prior to the index episode AND had service and Rx eligibility between 12 months prior and 6 months after the index episode AND have no claims for a BMD test during the 730 days prior to the index episode or a prescription for a drug to treat or prevent osteoporosis during the 365 days prior to the index episode National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, CB Version V1
27 Measure Description / Technical Specifications Measure Citation Persistence of Beta-Blocker Treatment After a Heart Attack Attributed Members ages 18 or older who were hospitalized for AMI and discharged from the hospital between July 1 of the prior to the and June 30 of the who have been taking a beta blocker consistently for at least six months post discharge. Attributed Members in the denominator who have 135 days supply of a beta blocker medication in the six months post AMI discharge Attributed Members hospitalized and discharged with an AMI between July 1 of the prior to the and June 30 of the, who do not have a contraindication to beta blockers (contraindications include: history of asthma or use of asthma medications, hypotension, 2 nd - or 3 rd -degree heart block or sinus bradycardia with no history of pacemaker, or COPD) 135 days supply of a beta blocker medication during the 6 months following date of discharge of AMI Age 18 s as of the end of the measurement AND meet criteria for Acute MI AND date of discharge of AMI between 180 and 545 days prior to end of the AND have no absolute contraindications for beta blockers. These include diagnoses for asthma, COPD, heart block >1 degree, hypotension, and sinus bradycardia, and Rx codes for asthma medications AND have Rx eligibility during the 6 months following the AMI episode date National Committee for Quality Assurance. HEDIS 2015 Measures. Vol. 2. Washington, DC: National Committee for Quality Assurance; CB Version V1
28 Measure Description / Technical Specifications Measure Citation Arthritis: Disease Modifying Antirheumatic Drug (DMARD) Therapy in RA Attributed Members with a diagnosis of RA and who were dispensed at least one ambulatory prescription for a diseasemodifying anti-rheumatic drug (DMARD) during the. Attributed Members in the denominator who were dispensed at least one ambulatory prescription for a disease-modifying antirheumatic drug (DMARD) during the Attributed Members 18 s old with two faceto-face physician encounters with different dates of service in an outpatient or non-acute inpatient setting during the first 11 months of the with any diagnosis of rheumatoid arthritis (RA). Excludes patients diagnosed with HIV or who were pregnant during the 1 Rx claim for DMARD during the Age 18 s old as of the end of the AND 2 medical claims for face-to-face physician encounters with different dates of service in an outpatient or non-acute inpatient setting, with a diagnosis of rheumatoid arthritis based on HEDIS criteria, during the first 11 months of the measurement AND no medical claims for HIV or pregnancy during the AND has continuous medical and Rx eligibility (as defined by NCQA/HEDIS) during the National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol 2, CB Version V1
29 Measure Description / Technical Specification Measure Citation Use of Appropriate Medications for People with Asthma Attributed Members age 5 to 56 during the who have persistent asthma and who were appropriately prescribed medication during the measurement. Attributed Members in the denominator who have at least one claim for an asthma controller medication. Attributed Members who meet HEDIS criteria for persistent asthma during or prior to the measurement with pharmacy benefits during the. Excludes Attributed Members with any history of emphysema, COPD, cystic fibrosis, and acute respiratory failure. Rx claim for HEDIS-defined asthma controller medication during the. Age 5 and 56 as of end of AND meet criteria for persistent asthma per HEDIS AND have service eligibility the prior to and during the measurement AND have Rx eligibility during the measurement AND no claims for asthma medication contraindications; these include emphysema, COPD, cystic fibrosis, and acute respiratory failure National Committee for Quality Assurance. HEDIS Washington, DC: National Committee for Quality Assurance. Technical Specifications Vol. 2, CB Version V1
Commercial Business Measurement Period Handbook-Medical Cost Target Model For Enhanced Personal Health Care Measurement Period beginning: 01/1/17
Commercial Business Measurement Period Handbook-Medical Cost Target Model For Enhanced Personal Health Care Measurement Period beginning: 01/1/17 CBMCT Version 010117 V3 Introduction: Welcome to your Commercial
More informationCommercial Business Medical Cost Target
Commercial Business Medical Cost Target Measurement Period Handbook For Enhanced Personal Health Care Measurement Period beginning: April 1, 2018 CBMCT 040118 V3 Introduction Welcome to your Commercial
More informationCommercial Business Medical Cost Target
Commercial Business Medical Cost Target Measurement Period Handbook For Enhanced Personal Health Care Measurement Period beginning: April 1, 2018 CBMCT 040118 V1 Introduction Welcome to your Commercial
More informationPatient-Centered Primary Care Scorecard Measure Specifications
Patient-Centered Primary Care Scorecard Measure Specifications Disclaimer of Currency: Material Owner documentation reflects the state of products, software, reports, and procedures as of the publication
More informationMedicare Advantage Measurement Period Handbook for Enhanced Personal Health Care Measurement Period beginning January 1, 2015
Medicare Advantage Measurement Period Handbook for Enhanced Personal Health Care Measurement Period beginning January 1, 2015 Amerivantage is an HMO plan with a contract with the New Mexico Medicare program.
More informationPatient-Centered Primary Care Scorecard Measures
Patient-Centered Primary Care Scorecard Measures Acute and Chronic Care Management Measures Medication Adherence Proportion of Days Covered (PDC): Oral Diabetes Identifies patients with at least two prescriptions
More informationQuality measures a for measurement year 2016
Quality measures a for measurement year 2016 Measure Description Eligible members Childhood immunizations b Adolescent immunizations b Children who turned 2 during the measurement and who were identified
More informationClinical Quality Measures Summary of Upcoming Enhancements
Upcoming coding enhancements will impact the logic behind the clinical quality indicators applicable to your practice specialty. Please refer to this grid for a summary of the coding enhancements and some
More informationMEASURING CARE QUALITY
MEASURING CARE QUALITY Region December 2013 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance
More information2017 HEDIS Measures. PREVENTIVE SCREENING 2017 Measure Quality Indicator
PREVENTIVE SCREENING Childhood Immunization Children who turn 2 during the Adolescent Immunization Adolescents who turn 13 during the Lead Screening Children who turn 2 during the Breast Cancer Screening
More informationIHA P4P Measure Manual Measure Year Reporting Year 2018
ADULT PREVENTIVE CARE IHA P4P Measure Manual Measure Year 2017 - Reporting Year 2018 *If line of business not labeled, measure is Commercial only Adult BMI (Medicare) 18-74 Medicare members ages 18-74
More informationPCMH 2018 Enrollment and Update August 25, 2017
PCMH 2018 Enrollment and Update August 25, 2017 Enrollment Requirements Anne Santifer HealthCare Innovations Department of Human Services 2018 Enrollment Requirements A physician practice that is enrolled
More informationMEASURING CARE QUALITY
MEASURING CARE QUALITY Region November 2016 For Clinical Effectiveness of Care Measures of Performance From: Healthcare Effectiveness Data and Information Set (HEDIS ) HEDIS is a set of standardized performance
More informationSTARS SYSTEM 5 CATEGORIES
TMG STARS 2018 1 2 STARS Program Implemented in 2008 by CMS. Tool to inform beneficiaries of quality of various health plans 5-star rating system Used to adjust payments to health plans (bonus to plans
More informationHEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications
HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications Fidelis SecureCare strives to provide quality healthcare to our membership as measured through HEDIS quality metrics.
More informationAnthem Blue Precision Quality Designation Methodology Summary 2017
This document outlines Anthem s Blue Precision methodology for measuring Physician Quality. Anthem has physician quality transparency programs for physicians practicing in the following specialties: Allergy/Immunology,
More informationQuality Corp Measures Description and Methodologies
Quality Corp Measures Description and Methodologies Overview: The Oregon Health Care Quality Corporation (Q Corp) is dedicated to improving the quality and affordability of health care in Oregon by leading
More informationQuality Corp Measures Description and Methodologies
Quality Corp Measures Description and Methodologies Overview: The Oregon Health Care Quality Corporation (Q Corp) is dedicated to improving the quality and affordability of health care in Oregon by leading
More informationCare1st Health Plan Taking Quality to the Next Level REPORTING YEAR HEDIS Summary - MPL (Measurement Year 2012)
Care1st Health Plan s Quality Improvement Department has been diligently working towards improving the Healthcare Effectiveness Data and Information Sets (HEDIS) results across all lines of business. HEDIS
More informationSUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES
Summary Table of Measures, Product Lines and Changes 1 SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES General Guidelines for Data Collection and Reporting Guidelines for Calculations and Sampling
More informationMulti-Specialty Quality Measure Information Sheet 2017
Prevention and Screening Adolescent Preventive Care Measures (APC) The percentage of adolescents 12-17 years of age who had at least one outpatient visit with a PCP or OB/ GYN practitioner during the measurement
More informationAdult HEDIS & STARs Measures
HEDIS AND MEDICARE STAR DOCUMENTATION & CODING GUIDE Adult HEDIS & STARs Measures Adult BMI Assessment (ABA) 18 74-year-old Antidepressant Medication Management (AMM) Breast Cancer Screening (BCS) Cervical
More informationThe BlueCompare SM Physician Designation Program
The BlueCompare SM Physician Designation Program Continuing escalation of health care costs has driven premiums and medical expenses to higher and higher levels each year, motivating employers and consumers
More informationHealthcare Effectiveness Data and Information Set Quality Assurance Reporting Requirements
HEDIS/QARR Healthcare Effectiveness Data and Information Set Quality Assurance Reporting Requirements 2015 Quick Reference Guide ADULTS Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis
More informationPreferred Care Partners. HEDIS Technical Standards
Preferred Care Partners HEDIS Technical Standards 1 HEDIS What is HEDIS HEDIS Overview Adults HEDIS Overview Pediatrics HEDIS is a registered trademark of the National Committee for Quality Assurance 2
More informationCOMMUNITY HEALTH GROUP HEDIS MEASURES (CY 2012) MEDICARE QUICK REFERENCE GUIDE FOR BILLING DEPARTMENT
HEDIS MEASURES (CY ) MEDICARE QUICK REFERENCE GUIDE FOR BILLING DEPARTMENT Care for Older Adults Colorectal Cancer Screening Annual Monitoring for Patients on Persistent Medications COA COL MPM Age Description
More information2018 P4P Overview 0518.PR.P.PP.1 6/18
2018 P4P Overview Agenda MHS Pay For Performance (P4P) Ambetter P4P Program Secure Web Reporting Question and Answer What You Will Learn 1. Measure Overviews & Specifications 2. Documentation Requirements
More informationHEDIS. Quick Reference Guide. For more information, visit
HEDIS Quick Reference Guide For more information, visit www.ncqa.org HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2017 Technical Specifications Michigan Complete Health Medicare-Medicaid Plan
More informationArkansas Blue Cross and Blue Shield (ABCBS) Patient Centered Medical Home (PCMH) Specifications Manual
Arkansas Blue Cross and Blue Shield (ABCBS) Patient Centered Medical Home (PCMH) Specifications Manual 2017 This document is a guide to the 2017 Arkansas Blue Cross and Blue Shield Patient-Centered Medical
More informationStar Measures At-A-Glance Guide
Star Measures At-A-Glance Guide This guide alerts you to important preventive care and services that you can provide to patients to help boost Star Ratings. ASSESSMENT AND SCREENING At WellCare, we value
More informationQuality Care Plus 2015 Primary Care Physician Incentive Program. Now includes Medicare patients!
Quality Care Plus 2015 Primary Care Physician Incentive Program Now includes Medicare patients! Health Partners Plans (HPP) would like to express our appreciation for the invaluable role our primary care
More informationStar Measures At-A-Glance Guide
Star Measures At-A-Glance Guide This guide alerts you to important preventive care and services that you can provide to patients to help boost Star Ratings. ASSESSMENT AND SCREENING At Easy Choice, we
More informationHEDIS. Quick Reference Guide. For more information, visit
HEDIS Quick Reference Guide For more information, visit www.ncqa.org HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2018 Technical Specifications Michigan Complete Health strives to provide
More informationChanges for Physician Measurement 2018
Changes for Physician Measurement 2018 Measure Name Guidelines for Physician Measurement Effectiveness of Care Changes Revised the Systematic Sampling Methodology to require organizations to report using
More information2018 Commercial HMO/POS HEDIS 1 Results
08 Commercial HMO/POS HEDIS Results Weight Assessment & Counseling for Nutrition & Physical Activity for Children/Adolescents HEDIS 06 CY 05 HEDIS 07 CY 06 HEDIS 08 CY 07 Compass BMI Percentile 70.47%
More informationQuality measures desktop reference for Medicaid providers
Quality measures desktop reference for Medicaid providers providers.amerigroup.com Please note: The information provided is based on 2016 technical specifications and is subject to change based on guidance
More informationQuality measures desktop reference for Medicaid providers
Quality measures desktop reference for Medicaid providers providers.amerigroup.com Please note: The information provided is based on 2016 technical specifications and is subject to change based on guidance
More information2016 General Practice/Family Practice Preferred Specialty Measure Set
1 0059 5 0081 41 N/A 50 N/A 65 0069, EHR 66 0002, EHR Effective Clinical Care Effective Clinical Care Effective Clinical Care Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients
More informationQuality measures desktop reference for Medicaid providers
Quality measures desktop reference for Medicaid providers Please note: The information provided is based on 2016 technical specifications and is subject to change based on guidance given by the National
More informationPATIENT-IMPACT SCORECARD
UNDERSTANDING THE GSC PATIENT-IMPACT SCORECARD What is the GSC Patient-Impact Scorecard? The GSC Patient-Impact Scorecard shows pharmacy performance scores for GSC patients during the period indicated.
More informationQuality measures desktop reference for Medicaid providers
Please note: The information provided is based on 2016 technical specifications and is subject to change based on guidance given by the National Committee for Quality Assurance (NCQA), the Centers for
More information2013 Performance Incentive Metrics
1 2013 Performance Incentive Metrics The Performance Incentive Subcommittee presents the following set of proposed 2013 MiPCT Performance Incentive Metrics for consideration and recommends they be approved
More informationAdvances in Alignment, Measurement, and Performance MY 2017 Results Highlights
Advances in Alignment, Measurement, and Performance MY 2017 Results Highlights Align. Measure. Perform. (AMP) Programs Launched in 2003, VBP4P is a statewide performance improvement program and one of
More information5 x 7 spiral bound - prints front and back sheets - 1/1 - black MEASURE DESCRIPTION
Requirements for Meeting Clinical Goals - Last Updated 11-1-2016 TABLE OF CONTENTS MEASURE ABBREVIATION AAB ABA ADD AMM AMR ART BCS CBP CCS CDC CDC CDC CDC CHL CWP CIS COL FUH IMA IET LBP MPM MEASURE DESCRIPTION
More informationQUALITY IMPROVEMENT Section 9
Quality Improvement Program The Plan s Quality Improvement Program serves to improve the health of its members through emphasis on health maintenance, education, diagnostic testing and treatment. The Quality
More informationHEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications
HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications MHS Health Wisconsin strives to provide quality healthcare to our membership as measured through HEDIS quality metrics.
More informationHEDIS Documentation and Coding Adult Guidelines 2017
HEDIS Documentation and Coding Adult Guidelines 2017 Reproduced with permission from HEDIS 2017, Volume 2: Technical Specifications for Health Plans by the National Committee for Quality Assurance (NCQA).
More informationHEDIS/CAHPS 101 August 13, 2012 Minnesota Measurement and Reporting Workgroup
HEDIS/CAHPS 101 Minnesota Measurement and Reporting Workgroup MNsure s Accessibility & Equal Opportunity (AEO) office can provide this information in accessible formats for individuals with disabilities.
More informationClinical Integration Quality Measures
Clinical Integration Quality Measures Valley Integrated Care Network (VIPN) is physician-driven, with physicians determining which quality measures will be used to improve overall quality of care. Purpose:
More informationClinical Quality Measure (CQM) Reporting In PCC EHR. Tim Proctor Users Conference 2017
Clinical Quality Measure (CQM) Reporting In PCC EHR Tim Proctor (tim@pcc.com) Users Conference 2017 Agenda Uses for CQM Reporting A review of each CQM report How they are calculated Required configuration
More informationNCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits
NCC Pediatrics Continuity Clinic Curriculum: Medical Home Module 2 Well Visits Overall Goal: To identify strategies for providing comprehensive care during a well visit. The provision of comprehensive
More informationQuality Measures Guide. Medicare Star Rating and HEDIS measures
Quality Measures Guide Medicare Star Rating and HEDIS measures February 2018 About the Quality Measures Guide A key component of our Quality Program is Healthcare Effectiveness Data and Information Set
More informationABCBS PCMH Specifications. ARKANSAS BLUE CROSS and BLUE SHIELD An Independent Licensee of the Blue Cross and Blue Shield Association
ABCBS PCMH 2016 Specifications An Independent Licensee of the Blue Cross and Blue Shield Association Table of Contents I. Terminology 3 II. Transformation Activities 2016 List of Activities 4 3 month 5-9
More informationHEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications
HEDIS Quick Reference Guide Updated to reflect NCQA HEDIS 2016 Technical Specifications IlliniCare Health strives to provide quality healthcare to our membership as measured through HEDIS quality metrics.
More informationNCQA Health Insurance Plan Ratings Methodology October 2014
NCQA Health Insurance Plan Ratings Methodology October 2014 REVISION CHART Date Published December 2013 April 2014 October 2014 Description Draft version Final version Updated measure list with 50% rule
More information2018 MIPS Reporting Family Medicine
2018 MIPS Reporting Family Medicine Quality Reporting Requirements: Report on 6 quality measures or a specialty measure set Include at least ONE outcome or high-priority measure Report on patients of All-Payers
More informationHEDIS QUICK REFERENCE GUIDE 2018
HEDIS HYBRID MEASURES (Hybrid measures are based on data retrieved from medical records and may include administrative data from claims) HEDIS MEASURE MEASURE DESCRIPTION HEDIS MEDICAL RECORD DOCUMENTATION
More informationHEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS )
STARS MEASURES 2015 HEALTHCARE EFFECTIVENESS DATA AND INFORMATION SET (HEDIS ) Developed by the National Committee for Quality Assurance (NCQA), HEDIS is the most widely used set of performance measures
More information2017 PCP INCENTIVE AWARD PROGRAM MEASURES & TIPS
Childhood Immunization Status (CIS) Combo 10 Immunizations for Adolescents (IMA) Combo 1 Lead Screening in Children (LSC) Immunizations completed prior to a child turning 2 years of age in 2017 as follows:
More informationImproving Quality of Care for Medicare Patients: Accountable Care Organizations
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE
More informationTrending Determinations by Measure
1100 13th Street NW, Third Floor Washington, DC 20005 phone 202.955.3500 fax 202.955.3599 www.ncqa.org TO: Interested Parties FROM: Cindy Ottone, Director, Policy DATE: March 2019 RE: HEDIS 1 2019 Measure
More informationMeasuring and Improving Quality in Accountable Care Organizations
Measuring and Improving Quality in Accountable Care Organizations Joachim Roski, PhD MPH Fellow, Economic Studies Managing Director, High Value Healthcare Initiative Overview ACOs and health care reform
More informationHEDIS/QARR 2017 Quick Reference Guide ALL MEASURES
2017 HEDIS s HEDIS/QARR 2017 Quick Reference Guide ALL MEASURES Measure Age Band Denominator Event Numerator Requirement Line of Business AAB Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis
More informationHEDIS/QARR 2018 Quick Reference Guide ALL MEASURES
2018 HEDIS Codes HEDIS/QARR 2018 Quick Reference Guide ALL MEASURES Code Age Band Denominator Event Numerator Requirement ADL AAB AAP ABA ADV Adolescent Preventive Care Avoidance of Antibiotic in Adults
More informationCommercial HMO/POS Effectiveness of Care Measure
Commercial HMO/POS Effectiveness of Care Measure HEDIS 2017 NCQA Quality Compass National Average Adult BMI Assessment 91.85% 76.17% Weight Assessment and Counseling for Nutrition and Physical Activity
More informationHEDIS 2017 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING
HEDIS 2017 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING ATTENTION-DEFICIT/HYPERACTIVITY DISORDER 1. Follow-up Care for Children Prescribed ADHD Medication (ADD) Percent children newly
More informationProvider Perspective of Quality Measurement
Provider Perspective of Quality Measurement The American Medical Group Association supports its members in enhancing population health and care for patients through integrated systems of care Improve
More information2019 HEDIS 1 Measures Healthcare Effectiveness Data and Information Set
209 HEDIS s Healthcare Effectiveness Data and Information Set *s collected with medical record review. Red= new/addition to measures Blue= Medicare only Prevention and Screening Adult Immunization Status
More informationGetting to Safe, Affordable, Effective, Patient-Centered Care: Good Data Are Only the Beginning
Getting to Safe, Affordable, Effective, Patient-Centered Care: Good Data Are Only the Beginning Dana Gelb Safran, Sc.D. Senior Vice President Performance Measurement & Improvement Transformation Vision:
More informationEvidence-Based Measure (EBMs) Definitions
Evidence-Based (EBMs) s This guide is a brief summary of the most commonly-used EBMs. All information is based on the MedInsight Evidence Based s (EBMs) User Guide (October 2015), compiled in a way most
More informationHEDIS 2014 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING
HEDIS 2014 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING DIABETES 1. Comprehensive Diabetes Care (CDC): Percentage of members 18-75 years of age with diabetes (type 1 and type 2) who had
More informationJan Feb Mar Apr May Jun Jul Aug Sep X X X X X X X. Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov X X X X X X X X X X X X X
Primary Prevention Breast Cancer Prevention Member: Mammography reminder letters to female members ages 51.5-74 who are overdue to get a mammogram Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Providers:
More informationThe clinical quality measures as selected by the Clinical Management subcommittee for 2016 for the adult population are:
For 2016 the Clinical Integration Program is moving its clinical quality measures from the Verisk Healthcare Quality and Risk Measures to the National Committee for Quality Assurance HEDIS based measures.
More informationSUMMARY TABLE OF MEASURE CHANGES
Summary Table of Measure 1 SUMMARY TABLE OF MEASURE CHANGES Guidelines for Physician Measurement Adult BMI Assessment Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
More informationConsensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0
Consensus Core Set: ACO and PCMH / Primary Care s 0018 Controlling High Blood Pressure patients 18 to 85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately
More informationClinical HEDIS Medicare Stars Quick Reference Guide
Clinical HEDIS Medicare Stars Quick Reference Guide MEASURE Adult BMI Assessment (ABA) Breast Cancer Screening (BCS) SPECIFICATIONS The percentage of members 18 74 years of age who had an outpatient visit
More informationThis guide alerts you to important preventive care and services that you can provide to patients to help boost Star Ratings.
2019 HEDIS AT-A-GLANCE GUIDE STAR MEASURES This guide alerts you to important preventive care and services that you can provide to patients to help boost Star Ratings. At WellCare, we value everything
More informationDana L. Gilbert Chief Operating Officer Sharon Rudnick Vice President Outpatient Care Management
Ambulatory Sensitive Admissions Dana L. Gilbert Chief Operating Officer Sharon Rudnick Vice President Outpatient Care Management 1 Sites Of Care Advocate Health Care 12 Hospitals 10 acute care hospitals
More informationHEDIS Adult. Documentation and Coding Guidelines Medical record documentation required. Measure description. Coding ICD-10: Z68.1 Z68.45, Z68.
HEDIS Adult Documentation and Guidelines 2017 description Adult BMI Assessment (ABI) Members 18 74 years of age who had an outpatient visit and whose body mass index (BMI) was documented during the measurement
More informationTENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes
TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 3 Episodes Respiratory Infection (RI); Pneumonia (PNA); Inpatient Urinary Tract Infection (UTI-I; Outpatient Urinary
More informationCLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016
CLINICAL PROCESS IMPROVEMENT INITIATIVE (CPII) EFFICIENCY REPORT EXPLANATION January 4, 2016 WHAT IS AN EPISODE OF CARE? An episode of care is a grouping of a patient s health care claims for a unique
More informationRelease 17.0 Measure Changes
MiPCT Dashboard Q U I CK R E F ER E N C E Why are the Dashboard Measures Changing? The decision was made last year by the Stewardship and Performance Committee to move to HEDIS 2015 to support ICD-10 and
More informationSupplementary Online Content
Supplementary Online Content Friedberg MW, Rosenthal MB, Werner RM, Volpp KG, Schneider EC. Effects of a medical home and shared savings intervention on quality and utilization of care. Published online
More informationJAWDA Performance Quarterly KPI Profile (Clinic & Centers) March 2018
JAWDA Performance KPI Profile (Clinic & Centers) March 2018 1 P a g e Introduction: Physician office, clinic, and healthcare centers provide primary care function including health education, prevention,
More information2017 Performance Recognition Program PROVIDER INCENTIVE PROGRAM FOR: BCN HMO SM Commercial BCN Advantage SM Blue Cross Medicare Plus Blue SM PPO
Confidence comes with every card. 2017 Performance Recognition Program PROVIDER INCENTIVE PROGRAM FOR: BCN HMO SM Commercial BCN Advantage SM Blue Cross Medicare Plus Blue SM PPO Revised October 2017 CONTENTS
More informationBlue Cross Complete of Michigan Performance Recognition Program Incentive Materials 2017
Performance Recognition Program Incentive Materials 2017 Blue Cross Complete of Michigan 2017 Performance Recognition Program Dear Blue Cross Complete of Michigan-affiliated primary care physician or group
More information2017 Medicare STARs Provider Quality Indicators Guide
2017 Medicare STARs Provider Quality Indicators Guide Medicare STARs Rating Centers for Medicare & Medicaid Services (CMS) created a Five-Star Quality Rating System to help measure the quality in care
More informationValue Based Pay for Performance Results & Highlights Measurement Year September 2017
Value Based Pay for Performance Results & Highlights Measurement Year 2016 September 2017 IHA s Value Based Pay for Performance (VBP4P) ~200 Medical Groups & IPAs 9 Health Plans Common Measurement Public
More informationKey Quality of Care Measures. Blue Cross Blue Shield of Michigan Traditional, PPO and POS Members. Fourth Quarter 2003
Key Quality of Care Measures Blue Cross Blue Shield of Michigan Traditional, PPO and POS Members Fourth Quarter 2003 Blue Cross Blue Shield of Michigan is a nonprofit corporation and independent licensee
More informationBridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide
Bridges to Excellence Chronic Obstructive Pulmonary Disease Care Recognition Program Guide Altarum Bridges to Excellence 3520 Green Court, Suite 300 Ann Arbor, MI 48105 bte@altarum.org www.bridgestoexcellence.org
More informationHEDIS 2015 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING
HEDIS 2015 MQIC MEASURES SUMMARY LISTING FOR ANNUAL PERFORMANCE REPORTING DIABETES 1. Comprehensive Diabetes Care (CDC): Percentage of members 18-75 years of age with diabetes (type 1 and type 2) who had
More informationQIP/HEDIS Measure Webinar Series
QIP/HEDIS Measure Webinar Series September 26, 2017 Presenters: Partnership HealthPlan Quality Department Partnership HealthPlan of California To avoid echoes and feedback, we request that you use the
More informationB&T Format. New Measures. Better health care. Better choices. Better health.
1100 13th Street NW, Third Floor Washington, DC 20005 phone 202.955.3500 fax 202.955.3599 www.ncqa.org TO: Interested Organizations FROM: Patrick Dahill, Assistant Vice President, Policy DATE: February
More informationTable 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings
CMS-1345-P 174 Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings AIM: Better Care for Individuals 1. Patient/Care Giver Experience
More informationCombining Risk Adjustment and HEDIS to Improve Quality of Care. Colleen Gianatasio, CPC, CPC-P, CPMA, CPC-I, CRC
Combining Risk Adjustment and HEDIS to Improve Quality of Care Colleen Gianatasio, CPC, CPC-P, CPMA, CPC-I, CRC Agenda Improving primary care in today s health care environment Risk adjustment basics (using
More informationImplementing Performance Measurement Programs: The Blue Cross Blue Shield of Massachusetts Perspective
Implementing Performance Measurement Programs: The Blue Cross Blue Shield of Massachusetts Perspective Dana Gelb Safran, Sc.D. Senior Vice President Performance Measurement and Improvement Massachusetts
More informationQBPC Claims Based Provider Quick Reference Guide
QBPC Claims Based Provider Quick Reference Guide Category: Diabetes Chronic Suite ICD-10-CM diagnosis HbA1c Test Codes LOINC Evidence of Treatment for Nephropathy Codes E10; E11; E13 83036-37 17856-6,
More informationOverview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists
Overview of Current Quality Measures that can be Impacted by Ambulatory Pharmacists Measure Name Measure Domain Measure Focus Comment/Explanation CMS Value-based Purchasing Program (CMS VBP) AMI 30-day
More informationFor Electronic Measure Specification Information go to:
Diabetes Recognition NQF 0421 PQRI 128 Title: Adult Weight Screening and Follow-Up Description: Percentage of patients aged 18 years and older with a calculated BMI in the past six months or during the
More informationB&T Format. New Measures. 2 CAHPS is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).
TO: Interested Organizations FROM: Patrick Dahill, Assistant Vice President, Policy DATE: February 4, 2018 RE: 2018 Accreditation Benchmarks and Thresholds This document reports national benchmarks and
More information